{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T23:23:21Z","timestamp":1768778601724,"version":"3.49.0"},"reference-count":31,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.3892\/ijmm.2017.2879","type":"journal-article","created":{"date-parts":[[2017,2,6]],"date-time":"2017-02-06T11:02:32Z","timestamp":1486378952000},"page":"749-756","source":"Crossref","is-referenced-by-count":32,"title":["Hepatic HNF1 transcription factors control the induction of PCSK9 mediated by rosuvastatin in normolipidemic hamsters"],"prefix":"10.3892","volume":"39","author":[{"given":"Bin","family":"Dong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amar Bahadur","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikram Ravindra","family":"Shende","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingwen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,2,6]]},"reference":[{"key":"key20180107234745_b1-ijmm-39-03-0749","doi-asserted-by":"crossref","first-page":"18602","DOI":"10.1074\/jbc.M702027200","article-title":"Binding of proprotein convertase subtilisin\/kexin type 9 to epidermal growth factor-like repeat A of low density lipoprotein receptor decreases receptor recycling and increases degradation","volume":"282","author":"Zhang","year":"2007","journal-title":"J Biol Chem"},{"key":"key20180107234745_b2-ijmm-39-03-0749","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1172\/JCI29383","article-title":"Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and in livers of parabiotic mice","volume":"116","author":"Lagace","year":"2006","journal-title":"J Clin Invest"},{"key":"key20180107234745_b3-ijmm-39-03-0749","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1373\/clinchem.2007.099747","article-title":"Plasma PCSK9 concentrations correlate with LDL and total cholesterol in diabetic patients and are decreased by fenofibrate treatment","volume":"54","author":"Lambert","year":"2008","journal-title":"Clin Chem"},{"key":"key20180107234745_b4-ijmm-39-03-0749","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1210\/jc.2009-0141","article-title":"Genetic and metabolic determinants of plasma PCSK9 levels","volume":"94","author":"Lakoski","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180107234745_b5-ijmm-39-03-0749","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/1755-5922.12056","article-title":"An update on the clinical development of proprotein convertase subtilisin kexin 9 inhibitors, novel therapeutic agents for lowering low-density lipoprotein cholesterol","volume":"32","author":"Ling","year":"2014","journal-title":"Cardiovasc Ther"},{"key":"key20180107234745_b6-ijmm-39-03-0749","doi-asserted-by":"crossref","first-page":"12027","DOI":"10.1073\/pnas.1534923100","article-title":"Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes","volume":"100","author":"Horton","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107234745_b7-ijmm-39-03-0749","first-page":"2109","article-title":"Novel putative SREBP and LXR target genes identified by microarray analysis in liver of cholesterol-fed mice","volume":"44","author":"Maxwell","year":"2003","journal-title":"J ipid Res"},{"key":"key20180107234745_b8-ijmm-39-03-0749","doi-asserted-by":"crossref","first-page":"28885","DOI":"10.1074\/jbc.M109.052407","article-title":"Hepatocyte nuclear factor 1alpha plays a critical role in PCSK9 gene transcription and regulation by the natural hypocholesterolemic compound berberine","volume":"284","author":"Li","year":"2009","journal-title":"J Biol Chem"},{"key":"key20180107234745_b9-ijmm-39-03-0749","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1161\/01.ATV.0000134621.14315.43","article-title":"Statins upregulate PCSK9, the gene encoding the proprotein convertase neural apoptosis-regulated convertase-1 implicated in familial hypercholesterolemia","volume":"24","author":"Dubuc","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key20180107234745_b10-ijmm-39-03-0749","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1194\/jlr.M700443-JLR200","article-title":"Sterol-dependent regulation of proprotein convertase subtilisin\/kexin type 9 expression by sterol-regulatory element binding protein-2","volume":"49","author":"Jeong","year":"2008","journal-title":"J Lipid Res"},{"key":"key20180107234745_b11-ijmm-39-03-0749","doi-asserted-by":"crossref","first-page":"e000028","DOI":"10.1161\/JAHA.112.000028","article-title":"Elevated PCSK9 levels in untreated patients with heterozygous or homozygous familial hypercholesterolemia and the response to high-dose statin therapy","volume":"2","author":"Raal","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"key20180107234745_b12-ijmm-39-03-0749","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1194\/jlr.M003566","article-title":"Strong induction of PCSK9 gene expression through HNF1alpha and SREBP2: Mechanism for the resistance to LDL-cholesterol lowering effect of statins in dyslipidemic hamsters","volume":"51","author":"Dong","year":"2010","journal-title":"J Lipid Res"},{"key":"key20180107234745_b13-ijmm-39-03-0749","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.hep.2003.09.034","article-title":"Transcription factors in liver development, differentiation, and regeneration","volume":"38","author":"Costa","year":"2003","journal-title":"Hepatology"},{"key":"key20180107234745_b14-ijmm-39-03-0749","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1101\/gad.5.6.1042","article-title":"HNF-1\u03b1 and HNF-1\u03b2 (vHNF-1) share dimerization and homeo domains, but not activation domains, and form heterodimers in vitro","volume":"5","author":"Mendel","year":"1991","journal-title":"Genes Dev"},{"key":"key20180107234745_b15-ijmm-39-03-0749","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1172\/JCI61919","article-title":"Regulation of hepatic LDL receptors by mTORC1 and PCSK9 in mice","volume":"122","author":"Ai","year":"2012","journal-title":"J Clin Invest"},{"key":"key20180107234745_b16-ijmm-39-03-0749","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1128\/MCB.01389-08","article-title":"Hnf1\u03b1 (MODY3) controls tissue-specific transcriptional programs and exerts opposed effects on cell growth in pancreatic islets and liver","volume":"29","author":"Servitja","year":"2009","journal-title":"Mol Cell Biol"},{"key":"key20180107234745_b17-ijmm-39-03-0749","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1194\/jlr.M052969","article-title":"Reduction of circulating PCSK9 and LDL-C levels by liver-specific knockdown of HNF1\u03b1 in normolipidemic mice","volume":"56","author":"Shende","year":"2015","journal-title":"J Lipid Res"},{"key":"key20180107234745_b18-ijmm-39-03-0749","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.atherosclerosis.2015.01.013","article-title":"High-fructose feeding promotes accelerated degradation of hepatic LDL receptor and hypercholesterolemia in hamsters via elevated circulating PCSK9 levels","volume":"239","author":"Dong","year":"2015","journal-title":"Atherosclerosis"},{"key":"key20180107234745_b19-ijmm-39-03-0749","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1161\/ATVBAHA.115.305688","article-title":"Role of insulin in the regulation of proprotein convertase subtilisin\/kexin type 9","volume":"35","author":"Miao","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key20180107234745_b20-ijmm-39-03-0749","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.atherosclerosis.2013.08.028","article-title":"Inverse relationship between LDL cholesterol and PCSK9 plasma levels in dyslipidemic cynomolgus monkeys: Effects of LDL lowering by ezetimibe in the absence of statins","volume":"231","author":"Hentze","year":"2013","journal-title":"Atherosclerosis"},{"key":"key20180107234745_b21-ijmm-39-03-0749","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1074\/jbc.M114.597229","article-title":"Inhibition of PCSK9 transcription by berberine involves down-regulation of hepatic HNF1\u03b1 protein expression through the ubiquitin-proteasome degradation pathway","volume":"290","author":"Dong","year":"2015","journal-title":"J Biol Chem"},{"key":"key20180107234745_b22-ijmm-39-03-0749","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1194\/jlr.M010603","article-title":"Janus kinase activation by cytokine oncostatin M decreases PCSK9 expression in liver cells","volume":"52","author":"Cao","year":"2011","journal-title":"J Lipid Res"},{"key":"key20180107234745_b23-ijmm-39-03-0749","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.atherosclerosis.2012.08.012","article-title":"Delineation of molecular pathways that regulate hepatic PCSK9 and LDL receptor expression during fasting in normolipidemic hamsters","volume":"224","author":"Wu","year":"2012","journal-title":"Atherosclerosis"},{"key":"key20180107234745_b24-ijmm-39-03-0749","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejphar.2015.03.099","article-title":"Novel therapeutic agents for the treatment of hypercholesterolemia","volume":"763","author":"Verbeek","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"key20180107234745_b25-ijmm-39-03-0749","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrcardio.2015.51","article-title":"Dyslipidaemia. Assessing the efficacy and safety of evolocumab and alirocumab","volume":"12","author":"Huynh","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"key20180107234745_b26-ijmm-39-03-0749","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.tcm.2015.01.009","article-title":"PCSK9 inhibition in patients with hypercholesterolemia","volume":"25","author":"Desai","year":"2015","journal-title":"Trends Cardiovasc Med"},{"key":"key20180107234745_b27-ijmm-39-03-0749","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1194\/jlr.M019927","article-title":"Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia","volume":"53","author":"Yin","year":"2012","journal-title":"J Lipid Res"},{"key":"key20180107234745_b28-ijmm-39-03-0749","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/S0022-2275(20)35728-X","article-title":"Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans","volume":"34","author":"Dietschy","year":"1993","journal-title":"J Lipid Res"},{"key":"key20180107234745_b29-ijmm-39-03-0749","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0005-2760(91)90080-2","article-title":"Effects of hyperlipidemias in hamsters on lipid transfer protein activity and unidirectional cholesteryl ester transfer in plasma","volume":"1083","author":"Quig","year":"1991","journal-title":"Biochim Biophys Acta"},{"key":"key20180107234745_b30-ijmm-39-03-0749","doi-asserted-by":"crossref","first-page":"8416","DOI":"10.1074\/jbc.275.12.8416","article-title":"Mechanisms of hepatic very low density lipoprotein overproduction in insulin resistance. Evidence for enhanced lipoprotein assembly, reduced intracellular ApoB degradation, and increased microsomal triglyceride transfer protein in a fructose-fed hamster model","volume":"275","author":"Taghibiglou","year":"2000","journal-title":"J Biol Chem"},{"key":"key20180107234745_b31-ijmm-39-03-0749","doi-asserted-by":"crossref","first-page":"e7855","DOI":"10.1371\/journal.pone.0007855","article-title":"Species-specific differences in the expression of the HNF1A, HNF1B and HNF4A genes","volume":"4","author":"Harries","year":"2009","journal-title":"PLoS One"}],"container-title":["International Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijmm.2017.2879\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T16:07:50Z","timestamp":1658592470000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijmm.2017.2879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,6]]},"references-count":31,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,2,6]]},"published-print":{"date-parts":[[2017,3]]}},"alternative-id":["10.3892\/ijmm.2017.2879"],"URL":"https:\/\/doi.org\/10.3892\/ijmm.2017.2879","relation":{},"ISSN":["1107-3756","1791-244X"],"issn-type":[{"value":"1107-3756","type":"print"},{"value":"1791-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,6]]}}}